Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.

A M Feldman; A E Cates; W B Veazey; R E Hershberger; M R Bristow; K L Baughman; W A Baumgartner; C Van Dop

doi:10.1172/JCI113569

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Feldman, A. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Cates, A. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Veazey, W. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Hershberger, R. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Bristow, M. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Baughman, K. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Baumgartner, W. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Van Dop, C. in: JCI | PubMed | Google Scholar

Published in Volume 82, Issue 1 on July 1, 1988
J Clin Invest. 1988;82(1):189–197. https://doi.org/10.1172/JCI113569.
© 1988 The American Society for Clinical Investigation

Published July 1, 1988 - Version history

Human heart failure is associated with a diminished contractile response to beta-adrenergic agonists. We hypothesized that alterations in the activity of a guanine nucleotide-binding regulatory protein (G protein) might be partially responsible for this abnormality. We therefore measured the activity of G proteins in failing human myocardium utilizing bacterial toxin-catalyzed ADP ribosylation. The activity of a 40,000-mol wt pertussis toxin substrate (alpha G40) was increased by 36% in failing human hearts when compared with nonfailing controls. In contrast, there was no change in the level of the stimulatory regulatory subunit (Gs). The increased activity in alpha G40 was associated with a 30% decrease in basal as well as 5'-guanylyl imidodiphosphate-stimulated adenylate cyclase activity. These data suggest that increased alpha G40 activity is a new marker for failing myocardium and may account at least in part for the diminished responsiveness to beta 1-adrenergic agonists in the failing human heart.

Images.

Version 1 (July 1, 1988): No description

Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.

A M Feldman, A E Cates, W B Veazey, R E Hershberger, M R Bristow, K L Baughman, W A Baumgartner, and C Van Dop

Article tools

Metrics

Go to

Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.

A M Feldman, A E Cates, W B Veazey, R E Hershberger, M R Bristow, K L Baughman, W A Baumgartner, and C Van Dop

Article tools

Metrics

Go to

Sign up for email alerts